MPB Mid Penn Bancorp
$34.34▼ -0.19%
Financials
Other
After hours
$34.34▲ +0.00%
Oct 27, 4:00 PM ET
Volume 131.5K
Avg Volume (10D) 152.8K
Key Metrics & Fundamentals
Market Cap
$870.01M
P/E Ratio
11.8
Div Yield
2.67%
52W Range
27.98 - 39.15
% vs 50 MA
-5.50%
% vs 200 MA
-0.01%
RSI-14
36.7
MACD Histogram
-0.1700
Beta (1Y vs SPY)
0.42
Free Cash Flow
$31.21M
Gross Rev
$75.17M
Gross Profit
$75.17M
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
$27.57M
Net Income
$21.69M
EPS (Diluted)
0.85
Price & Volume History
Loading chart…
Recent News

Mid Penn Bancorp (MPB) Stock Drops After Q3 Earnings Margin Softens
Simply Wall St. · Oct 23, 2026 5:10 AM ET
Mid Penn Bancorp Q3 Adjusted Earnings, Revenue Rise
MT Newswires · Oct 22, 2026 3:25 AM ET

Mid Penn Bancorp, Inc. Reports Third Quarter Earnings and Declares 64th Consecutive Quarterly Dividend
Business Wire · Oct 21, 2026 9:15 PM ET

Compared to Estimates, Mid Penn Bancorp (MPB) Q3 Earnings: A Look at Key Metrics
Zacks · Oct 21, 2026 7:00 PM ET

Mid Penn Bancorp (MPB) Q3 Earnings Match Estimates
Zacks · Oct 21, 2026 6:50 PM ET

Mid Penn Bancorp (MPB) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 21, 2026 9:00 AM ET

Bridgewater (BWB) Q3 Earnings and Revenues Beat Estimates
Zacks · Oct 20, 2026 4:45 PM ET

Insider Buying Is Rising at These 3 Regional Banks, But the Details Matter
MarketBeat · Oct 19, 2026 12:50 PM ET

Are You Looking for a High-Growth Dividend Stock?
Zacks · Oct 9, 2026 10:45 AM ET

Mid Penn Bank Names Christopher Nestore Chief Risk Officer
Business Wire · Oct 8, 2026 3:36 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MPB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.